Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (261-270 of 333) with videos related to

Pageof 34
Sort By:
Public Health in Practice (Oxford, England)|April 20, 2026
Economic benefit of expanding mammography screening for breast cancer in Colombia: A cost modelling analysisAna María Osorio, Daniel Samacá-Samacá, Melissa Diaz-Puentes, et al.
Frontiers in Oncology|June 15, 2026
Trop-2 expression is associated with poor survival in pleural mesotheliomaAlejandro Aviles-Salas, Norma Hernández-Pedro, Enrique Caballé-Perez, et al.
Therapeutic Advances in Respiratory Disease|July 10, 2020
Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countriesAndrés F Cardona, Oscar Arrieta, Alejandro Ruiz-Patiño, et al.
Targeted Oncology|June 17, 2017
Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP)Andrés F Cardona, Oscar Arrieta, Martín Ignacio Zapata, et al.
JCO Global Oncology|December 4, 2025
Challenges and Opportunities for Cancer Clinical Trials Development in Latin AmericaJuan Manuel Garzón-Dangond, Oscar Arrieta, Pablo Mandó, et al.
Archives of Medical Research|February 14, 2026
Corrigendum to "Narrowing the Gap: Understanding Lung Cancer Care Intervals and Their Barriers in Latin American Low and Middle-Income Countries" [Archives of Medical Research 56 (2025) 103202/Article Number ARCMED-D-24-00358]Oscar Arrieta, Cittim B Palomares-Palomares, Ana Pamela Gómez-García, et al.
JAMA Oncology|April 10, 2020
Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical TrialOscar Arrieta, Feliciano Barrón, Laura Alejandra Ramírez-Tirado, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM populationDavid Heredia, Luis Mas, Andres F Cardona, et al.
Archives of Medical Research|March 21, 2025
Narrowing the Gap: Understanding Lung Cancer Care Intervals and Their Barriers in Latin American Low and Middle-Income CountriesOscar Arrieta, Cittim B Palomares-Palomares, Ana Pamela Gómez-García, et al.
Oncotarget|December 8, 2016
BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutationsAndrés F Cardona, Leonardo Rojas, Beatriz Wills, et al.
Pageof 34

Showing results (261-270 of 333) with videos related to

Sort By:
Pageof 34
Public Health in Practice (Oxford, England)|April 20, 2026
Economic benefit of expanding mammography screening for breast cancer in Colombia: A cost modelling analysisAna María Osorio, Daniel Samacá-Samacá, Melissa Diaz-Puentes, et al.
Frontiers in Oncology|June 15, 2026
Trop-2 expression is associated with poor survival in pleural mesotheliomaAlejandro Aviles-Salas, Norma Hernández-Pedro, Enrique Caballé-Perez, et al.
Therapeutic Advances in Respiratory Disease|July 10, 2020
Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countriesAndrés F Cardona, Oscar Arrieta, Alejandro Ruiz-Patiño, et al.
Targeted Oncology|June 17, 2017
Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP)Andrés F Cardona, Oscar Arrieta, Martín Ignacio Zapata, et al.
JCO Global Oncology|December 4, 2025
Challenges and Opportunities for Cancer Clinical Trials Development in Latin AmericaJuan Manuel Garzón-Dangond, Oscar Arrieta, Pablo Mandó, et al.
Archives of Medical Research|February 14, 2026
Corrigendum to "Narrowing the Gap: Understanding Lung Cancer Care Intervals and Their Barriers in Latin American Low and Middle-Income Countries" [Archives of Medical Research 56 (2025) 103202/Article Number ARCMED-D-24-00358]Oscar Arrieta, Cittim B Palomares-Palomares, Ana Pamela Gómez-García, et al.
JAMA Oncology|April 10, 2020
Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical TrialOscar Arrieta, Feliciano Barrón, Laura Alejandra Ramírez-Tirado, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM populationDavid Heredia, Luis Mas, Andres F Cardona, et al.
Archives of Medical Research|March 21, 2025
Narrowing the Gap: Understanding Lung Cancer Care Intervals and Their Barriers in Latin American Low and Middle-Income CountriesOscar Arrieta, Cittim B Palomares-Palomares, Ana Pamela Gómez-García, et al.
Oncotarget|December 8, 2016
BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutationsAndrés F Cardona, Leonardo Rojas, Beatriz Wills, et al.
Pageof 34